Through the Rapid Scenario Evaluation (RSE) initiative, pharma companies can apply for an evaluation of a drug development project or portfolio that has been impacted by the pandemic. Based on input (e.g. via Excel) from the customer, Captario creates an end-to-end model and evaluates different mitigation scenarios. The analysis is returned in no more than 1-3 days from the day of input arrival. To maximize speed Captario delivers the Rapid Scenario Evaluation with a CDA in place and free of charge.
Read more here.